Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Pyruvate Kinase Deficiency · Sickle Cell Disease · AGIO

Agios Netherlands

Agios Netherlands B.V.

Agios Netherlands clinical programs — 45 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
CAMBRIDGE, MA, NL HQ
1978 Founded
20 Employees
Public company Type
AGIO · NYSE Ticker
Company details
Status
Public
HQ
CAMBRIDGE, MA, NL
Founded
1978
Employees
20
Programs
45
Drugs
15
Patents
93
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Agios Netherlands projects

45 ClinicalTrials.gov programs sponsored by Agios Netherlands.

Agios Netherlands has 45 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

45 programs

Clinical programs

  1. AG-348

    Agios Netherlands B.V.

    Pyruvate Kinase Deficiency

    phase 3 small molecule completed

    2 trials

  2. Mitapivat

    Agios Netherlands B.V.

    Pediatric Pyruvate Kinase Deficiency

    phase 3 small molecule active

    2 trials

  3. Mitapivat

    Agios Netherlands B.V.

    Sickle Cell Disease

    phase 3 small molecule active

    2 trials

  4. Mitapivat

    Agios Netherlands B.V.

    Non-Transfusion-dependent Alpha-Thalassemia

    phase 3 small molecule active

    1 trial

  5. Mitapivat Matched Placebo

    Agios Netherlands B.V.

    Transfusion-dependent Alpha-Thalassemia

    phase 3 small molecule active

    1 trial

  6. Placebo

    Agios Netherlands B.V.

    Pyruvate Kinase Deficiency

    phase 3 small molecule completed

    1 trial

  7. Placebo Matching Mitapivat

    Agios Netherlands B.V.

    Transfusion-dependent Alpha-Thalassemia

    phase 3 small molecule active

    1 trial

  8. Placebo Matching Mitapivat

    Agios Netherlands B.V.

    Non-Transfusion-dependent Alpha-Thalassemia

    phase 3 small molecule active

    1 trial

  9. AG-120

    Agios Netherlands B.V.

    Chondrosarcoma

    phase 2 small molecule active

    1 trial

  10. AG-348

    Agios Netherlands B.V.

    Thalassemia

    phase 2 small molecule active

    1 trial

  11. Enasidenib

    Agios Netherlands B.V.

    Hematologic Neoplasms

    phase 2 small molecule completed

    1 trial

  12. Mitapivat

    Agios Netherlands B.V.

    Anemia

    phase 2 small molecule active

    1 trial

  13. Tebapivat

    Agios Netherlands B.V.

    Myelodysplastic Syndromes

    phase 2 small molecule active

    1 trial

  14. Tebapivat

    Agios Netherlands B.V.

    Sickle Cell Disease

    phase 2 small molecule active

    1 trial

  15. ivosidenib and nivolumab

    Agios Netherlands B.V.

    Advanced Solid Tumor

    phase 2 small molecule completed

    1 trial

  16. AG-120 (Ivosidenib)

    Agios Netherlands B.V.

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  17. AG-181

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  18. AG-181

    Agios Netherlands B.V.

    Phenylketonuria

    phase 1 small molecule active

    1 trial

  19. AG-236

    Agios Netherlands B.V.

    Healthy Participants

    phase 1 small molecule active

    1 trial

  20. AG-348

    Agios Netherlands B.V.

    Healthy

    phase 1 small molecule completed

    1 trial

  21. AG-348

    Agios Netherlands B.V.

    Healthy Volunteer

    phase 1 small molecule completed

    2 trials

  22. AG-348

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  23. AG-348

    Agios Netherlands B.V.

    Sickle Cell Disease

    phase 1 small molecule completed

    1 trial

  24. AG-348 Sequence A

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  25. AG-519

    Agios Netherlands B.V.

    Anemia

    phase 1 small molecule terminated

    1 trial

  26. AG-636

    Agios Netherlands B.V.

    Lymphoma

    phase 1 small molecule terminated

    1 trial

  27. AG-881

    Agios Netherlands B.V.

    Healthy Male Participants

    phase 1 small molecule completed

    1 trial

  28. AG-881

    Agios Netherlands B.V.

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  29. AG-946

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  30. AG120

    Agios Netherlands B.V.

    Healthy

    phase 1 small molecule completed

    2 trials

  31. AG221

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  32. AG881

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  33. AG881

    Agios Netherlands B.V.

    Acute Myeloid Leukemia (AML)

    phase 1 small molecule completed

    1 trial

  34. AG881 Formulation 1

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  35. Ivosidenib

    Agios Netherlands B.V.

    IDH1 Mutation Myeloid Neoplasms

    phase 1 small molecule completed

    1 trial

  36. Mitapivat

    Agios Netherlands B.V.

    Moderate Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  37. Mitapivat

    Agios Netherlands B.V.

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  38. Mitapivat tablet

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  39. Mitapivat tablets

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  40. Placebo for Treatment A

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  41. [14C]-AG-120

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  42. [14C]-tebapivat

    Agios Netherlands B.V.

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  43. itraconazole

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  44. ivosidenib (AG-120)

    Agios Netherlands B.V.

    Healthy

    phase 1 small molecule completed

    1 trial

  45. Mitapivat

    Agios Netherlands B.V.

    Pyruvate Kinase Deficiency

    approved small molecule active

    2 trials

Frequently asked questions

How many clinical projects does Agios Netherlands have?

45 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.